Qiu Zhao
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 12
- SARS-CoV-2 and COVID-19 Research 9
- Neurology top 1%
- Long-Term Effects of COVID-19 8
- Cancer Research top 2%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 12
-
- Ferroptosis and cancer prognosis 18
-
- RNA modifications and cancer 14
- Epigenetics and DNA Methylation 10
- Ubiquitin and proteasome pathways 8
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Qiu Zhao
97 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Infectious Diseases 2.3k
- Neurology 1.2k
- Cancer Research 698
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Qiu Zhao
This map shows the geographic impact of Qiu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Zhao more than expected).
Fields of papers citing papers by Qiu Zhao
This network shows the impact of papers produced by Qiu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Zhao. The network helps show where Qiu Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiu Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 7 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 66 | |
| 11 | Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways | 2020 | 1 |
| 12 | 2020 | 339 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 29 | |
| 16 | 2019 | 98 | |
| 17 | 2018 | 48 | |
| 18 | 2018 | 19 | |
| 19 | 2017 | 2 | |
| 20 | Expressions of Notch-1,Jagged-1 and p-mTOR in pancreatic carcinoma and their significances | 2009 | 1 |
About Qiu Zhao
Qiu Zhao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 102 papers that have together received 5.1k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (18 papers), RNA modifications and cancer (14 papers), Pancreatic and Hepatic Oncology Research (12 papers), COVID-19 Clinical Research Studies (12 papers), Epigenetics and DNA Methylation (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Ubiquitin and proteasome pathways (8 papers) and Long-Term Effects of COVID-19 (8 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Neurology (1.2k citations) and Cancer Research (698 citations). Qiu Zhao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Haizhou Wang, Yongxi Zhang, Pingzheng Mo, Liping Deng, Shihui Song, Yong Xiong, Zhiyong Ma, Jiayan Nie, Jing Liu and Yunjiao Zhou. Their work appears in journals such as Cell Death and Disease, Cancer Science, Scientific Reports, Frontiers in Cell and Developmental Biology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.